We are in the middle of an ongoing data-driven revolution in the pharmaceutical industry. Data and analytics are reshaping how companies approach sales and marketing strategies – and customer experience.

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

Amidst the backdrop of evolving privacy regulations and the phasing out of traditional digital identifiers, the video explores the essential strategies pharmaceutical advertisers must adopt to navigate these industry challenges and accurately assess the real-world outcomes they are achieving from their advertising. This is a video recording of a speaking session produced in partnership with…

Pharma brand managers have a data problem: namely, they have access to so much of it that it can inundate their decision-making processes. We outline the best ways of streamlining the volume of information and separating the proverbial wheat from the chaff. This is a video recording of a speaking session produced in partnership with…

The use of insights derived from real-world data (RWD) for advertising planning and business development is table stakes, but getting access to that data and compiling insights can be an arduous and resource-intensive process. How does PurpleLab help healthcare advertisers utilize RWD insights? Watch this webinar with Hannah Lucas, Director of Product Management, Advertising, at…

While there has always been a significant focus on how to effectively educate and market products to patients and healthcare providers (HCPs) there is another group that pharmaceutical manufacturers, specifically– Medical Affairs and Marketing teams need to reach, educate, and influence: . KOLs, often the most experienced in a therapy area, who also may be…

Commercial launch strategies require research, insight gathering and decision-making for years in advance of FDA submission. These processes involve complex requirements and often involve timelines and project plans that are mapped out across functional teams and their agency partners. As teams move quickly into “launch mode”, there are many potential shifting priorities requiring contingency plans…